276 related articles for article (PubMed ID: 11860409)
1. The clinical and economic impact of competing management strategies for gastro-oesophageal reflux disease.
Ofman JJ; Dorn GH; Fennerty MB; Fass R
Aliment Pharmacol Ther; 2002 Feb; 16(2):261-73. PubMed ID: 11860409
[TBL] [Abstract][Full Text] [Related]
2. The cost-effectiveness of the omeprazole test in patients with noncardiac chest pain.
Ofman JJ; Gralnek IM; Udani J; Fennerty MB; Fass R
Am J Med; 1999 Sep; 107(3):219-27. PubMed ID: 10492314
[TBL] [Abstract][Full Text] [Related]
3. Low-dose or standard-dose proton pump inhibitors for maintenance therapy of gastro-oesophageal reflux disease: a cost-effectiveness analysis.
You JH; Lee AC; Wong SC; Chan FK
Aliment Pharmacol Ther; 2003 Mar; 17(6):785-92. PubMed ID: 12641500
[TBL] [Abstract][Full Text] [Related]
4. Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease.
Fass R; Ofman JJ; Gralnek IM; Johnson C; Camargo E; Sampliner RE; Fennerty MB
Arch Intern Med; 1999 Oct; 159(18):2161-8. PubMed ID: 10527293
[TBL] [Abstract][Full Text] [Related]
5. A one-year economic evaluation of six alternative strategies in the management of uninvestigated upper gastrointestinal symptoms in Canadian primary care.
Barkun AN; Crott R; Fallone CA; Kennedy WA; Lachaine J; Levinton C; Armstrong D; Chiba N; Thomson A; Veldhuyzen van Zanten S; Sinclair P; Escobedo S; Chakraborty B; Smyth S; White R; Kalra H; Nevin K
Can J Gastroenterol; 2010 Aug; 24(8):489-98. PubMed ID: 20711528
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness comparison of current proton-pump inhibitors to treat gastro-oesophageal reflux disease in the UK.
Remák E; Brown RE; Yuen C; Robinson A
Curr Med Res Opin; 2005 Oct; 21(10):1505-17. PubMed ID: 16238890
[TBL] [Abstract][Full Text] [Related]
7. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.
Gerson LB; Robbins AS; Garber A; Hornberger J; Triadafilopoulos G
Am J Gastroenterol; 2000 Feb; 95(2):395-407. PubMed ID: 10685741
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
Harris RA; Kuppermann M; Richter JE
Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of omeprazole as a cost-effective diagnostic test for gastro-oesophageal reflux disease.
Bate CM; Riley SA; Chapman RW; Durnin AT; Taylor MD
Aliment Pharmacol Ther; 1999 Jan; 13(1):59-66. PubMed ID: 9892880
[TBL] [Abstract][Full Text] [Related]
10. The cost of long term therapy for gastro-oesophageal reflux disease: a randomised trial comparing omeprazole and open antireflux surgery.
Myrvold HE; Lundell L; Miettinen P; Pedersen SA; Liedman B; Hatlebakk J; Julkunen R; Levander K; Lamm M; Mattson C; Carlsson J; Ståhlhammar NO;
Gut; 2001 Oct; 49(4):488-94. PubMed ID: 11559644
[TBL] [Abstract][Full Text] [Related]
11. Cost-utility of laparoscopic Nissen fundoplication versus proton pump inhibitors for chronic and controlled gastroesophageal reflux disease: a 3-year prospective randomized controlled trial and economic evaluation.
Goeree R; Hopkins R; Marshall JK; Armstrong D; Ungar WJ; Goldsmith C; Allen C; Anvari M
Value Health; 2011; 14(2):263-73. PubMed ID: 21402295
[TBL] [Abstract][Full Text] [Related]
12. "Proton-pump inhibitor-first" strategy versus "step-up" strategy for the acute treatment of reflux esophagitis: a cost-effectiveness analysis in Japan.
Habu Y; Maeda K; Kusuda T; Yoshino T; Shio S; Yamazaki M; Hayakumo T; Hayashi K; Watanabe Y; Kawai K
J Gastroenterol; 2005 Nov; 40(11):1029-35. PubMed ID: 16322946
[TBL] [Abstract][Full Text] [Related]
13. Cost analysis of endoscopic antireflux procedures: endoluminal plication vs. radiofrequency coagulation vs. treatment with a proton pump inhibitor.
Harewood GC; Gostout CJ
Gastrointest Endosc; 2003 Oct; 58(4):493-9. PubMed ID: 14520279
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of omeprazole and ranitidine in intermittent treatment of symptomatic gastro-oesophageal reflux disease.
Stålhammar NO; Carlsson J; Peacock R; Müller-Lissner S; Bigard MA; Porro GB; Ponce J; Hosie J; Scott M; Weir DG; Fulton C; Gillon K; Bardhan KD
Pharmacoeconomics; 1999 Nov; 16(5 Pt 1):483-97. PubMed ID: 10662395
[TBL] [Abstract][Full Text] [Related]
15. Cost effectiveness of proton pump inhibitors in gastro-oesophageal reflux disease without oesophagitis: comparison of on-demand esomeprazole with conventional omeprazole strategies.
Wahlqvist P; Junghard O; Higgins A; Green J
Pharmacoeconomics; 2002; 20(4):267-77. PubMed ID: 11950383
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of the RefluxStop device for management of refractory gastroesophageal reflux disease in Switzerland.
Harper S; Kartha M; Mealing S; Borbély YM; Zehetner J
J Med Econ; 2024; 27(1):805-815. PubMed ID: 38820006
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the dyspeptic patient: a cost-utility study.
Ebell MH; Warbasse L; Brenner C
J Fam Pract; 1997 Jun; 44(6):545-55. PubMed ID: 9191627
[TBL] [Abstract][Full Text] [Related]
18. Effects on the cost and utilization of proton pump inhibitors from adding over-the counter omeprazole to drug benefit coverage in a state employee health plan.
Harris BN; West DS; Johnson J; Hong SH; Stowe CD
J Manag Care Pharm; 2004; 10(5):449-55. PubMed ID: 15369428
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness model of endoscopic biopsy for eosinophilic esophagitis in patients with refractory GERD.
Miller SM; Goldstein JL; Gerson LB
Am J Gastroenterol; 2011 Aug; 106(8):1439-45. PubMed ID: 21448144
[TBL] [Abstract][Full Text] [Related]
20. The cost-effectiveness and budget impact of intravenous versus oral proton pump inhibitors in peptic ulcer hemorrhage.
Spiegel BM; Dulai GS; Lim BS; Mann N; Kanwal F; Gralnek IM
Clin Gastroenterol Hepatol; 2006 Aug; 4(8):988-997. PubMed ID: 16844422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
